{"id":5255,"date":"2012-11-01T00:00:00","date_gmt":"2012-11-01T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/index.php\/2012\/11\/01\/pmn1110-article03\/"},"modified":"2019-02-18T20:14:54","modified_gmt":"2019-02-18T20:14:54","slug":"pmn1110-article03","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/","title":{"rendered":"The Future of Pharma Marketing is Mobile, Unless\u2026: \u2026FDA&#8217;s &#8220;Enforcement Discretion&#8221; Remains Unclear"},"content":{"rendered":"<p>The Future of Pharma Marketing is Mobile, Unless\u2026        \u2026FDA&#8217;s &#8220;Enforcement Discretion&#8221; Remains Unclear<br \/><img loading=\"lazy\" decoding=\"async\" alt=\"Mobile Future\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2019\/02\/MobileFuture_200x167.jpg\" align=\"right\" border=\"1\" height=\"167\" width=\"200\" hspace=\"8\" vspace=\"8\"\/>You don&#8217;t need a crystal ball to know that the future of media is mobile. While pharmaceutical companies may not yet be advertising on mobile devices as they do on TV, websites, and magazines, they are developing health apps that run on Droid smartphones, iPhones and iPads. Many observers feel that the pharma industry lags behind other industries as far as having a mobile strategy is concerned. One of the factors that may be holding back pharma in its pursuit of a mobile strategy is the loomimg sepecter of FDA regulations.<\/p>\n<p>Topics include:<\/p>\n<ul>\n<li>Chart: Overall Strategy of Pharma Mobile Compared to Other Industries<\/li>\n<li>Video: Pharmaguy&#8217;s  POV Regarding Regulation of Pharma Mobile Medical Apps<\/li>\n<li>What Is and Is Not an &#8220;MMA&#8221;?<\/li>\n<li>Chart: FDA&#8217;s Mobile medical apps Proposed Scope for Oversight<\/li>\n<li>Comments from Industry Submitted to FDA<\/li>\n<ul>\n<li>Risk of &#8220;Squashing&#8221; the Startup Mobile Medical Industry<\/li>\n<li>Focus Should Be Solely on Apps that Involve Significant Risk to Patients<\/li>\n<li>Who&#8217;s Responsible for Recalls?<\/li>\n<li>Mobile Apps Based on Websites<\/li>\n<li>Clarify the Scope of FDA&#8217;s &#8220;Enforcement Discretion&#8221;<\/li>\n<\/ul>\n<\/ul>\n<p>Sorry. This article is not available at this time.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2012\/11\/tl_brdr2_trans.gif\" width=\"9\" height=\"9\" border=\"0\"\/><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2012\/11\/spacer.gif\" border=\"0\" width=\"1\" height=\"1\"\/><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2012\/11\/tr_brdr2_trans.gif\" width=\"9\" height=\"9\" border=\"0\"\/><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2012\/11\/spacer.gif\" border=\"0\" width=\"1\" height=\"1\"\/>Pharma Marketing NewsEmail Addr: \u00a0<img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2012\/11\/bl_brdr2_trans.gif\" width=\"9\" height=\"9\" border=\"0\"\/><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2012\/11\/spacer.gif\" border=\"0\" width=\"1\" height=\"1\"\/><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2012\/11\/br_brdr2_trans.gif\" width=\"9\" height=\"9\" border=\"0\"\/><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2012\/11\/spacer.gif\" border=\"0\" width=\"1\" height=\"1\"\/>    <\/p>\n<p>PMN1110-03<br \/>Issue: Vol. 11, No. 10: November 2012<\/p>\n<p\/><b>Find other articles in related Topic Areas:<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNeMktingReprints.htm\">eMarketing and ePromotion<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNDTCReprints.htm\">Direct-to-Consumer (DTC) Advertising &amp; Marketing<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNpatedReprints.htm\">Patient Education<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNRegComplianceReprints.htm\">Regulatory Compliance<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>You don&#8217;t need a crystal ball to know that the future of media is mobile. While pharmaceutical companies may not yet be advertising on mobile devices as they do on TV, websites, and magazines, they are developing health apps that run on Droid smartphones, iPhones and iPads. Many observers feel that the pharma industry lags behind other industries as far as having a mobile strategy is concerned. One of the factors that may be holding back pharma in its pursuit of a mobile strategy is the loomimg sepecter of FDA regulations.<\/p>\n","protected":false},"author":2,"featured_media":5336,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[61,6],"tags":[],"topic":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Future of Pharma Marketing is Mobile, Unless\u2026: \u2026FDA&#039;s &quot;Enforcement Discretion&quot; Remains Unclear - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Future of Pharma Marketing is Mobile, Unless\u2026: \u2026FDA&#039;s &quot;Enforcement Discretion&quot; Remains Unclear - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"You don&#039;t need a crystal ball to know that the future of media is mobile. While pharmaceutical companies may not yet be advertising on mobile devices as they do on TV, websites, and magazines, they are developing health apps that run on Droid smartphones, iPhones and iPads. Many observers feel that the pharma industry lags behind other industries as far as having a mobile strategy is concerned. One of the factors that may be holding back pharma in its pursuit of a mobile strategy is the loomimg sepecter of FDA regulations.\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2012-11-01T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-18T20:14:54+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2012\/11\/br_brdr2_trans.gif\" \/>\n\t<meta property=\"og:image:width\" content=\"9\" \/>\n\t<meta property=\"og:image:height\" content=\"9\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/gif\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/\",\"name\":\"The Future of Pharma Marketing is Mobile, Unless\u2026: \u2026FDA's \\\"Enforcement Discretion\\\" Remains Unclear - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2012-11-01T00:00:00+00:00\",\"dateModified\":\"2019-02-18T20:14:54+00:00\",\"author\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Future of Pharma Marketing is Mobile, Unless\u2026: \u2026FDA&#8217;s &#8220;Enforcement Discretion&#8221; Remains Unclear\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Future of Pharma Marketing is Mobile, Unless\u2026: \u2026FDA's \"Enforcement Discretion\" Remains Unclear - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/","og_locale":"en_US","og_type":"article","og_title":"The Future of Pharma Marketing is Mobile, Unless\u2026: \u2026FDA's \"Enforcement Discretion\" Remains Unclear - Pharma Marketing Network","og_description":"You don't need a crystal ball to know that the future of media is mobile. While pharmaceutical companies may not yet be advertising on mobile devices as they do on TV, websites, and magazines, they are developing health apps that run on Droid smartphones, iPhones and iPads. Many observers feel that the pharma industry lags behind other industries as far as having a mobile strategy is concerned. One of the factors that may be holding back pharma in its pursuit of a mobile strategy is the loomimg sepecter of FDA regulations.","og_url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/","og_site_name":"Pharma Marketing Network","article_published_time":"2012-11-01T00:00:00+00:00","article_modified_time":"2019-02-18T20:14:54+00:00","og_image":[{"width":9,"height":9,"url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2012\/11\/br_brdr2_trans.gif","type":"image\/gif"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/","name":"The Future of Pharma Marketing is Mobile, Unless\u2026: \u2026FDA's \"Enforcement Discretion\" Remains Unclear - Pharma Marketing Network","isPartOf":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2012-11-01T00:00:00+00:00","dateModified":"2019-02-18T20:14:54+00:00","author":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn1110-article03\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"The Future of Pharma Marketing is Mobile, Unless\u2026: \u2026FDA&#8217;s &#8220;Enforcement Discretion&#8221; Remains Unclear"}]},{"@type":"WebSite","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/5255"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=5255"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/5255\/revisions"}],"predecessor-version":[{"id":5337,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/5255\/revisions\/5337"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/5336"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=5255"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=5255"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=5255"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=5255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}